tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BDRX Stock Latest News

Upcoming Stock Splits This Week (July 28 to August 1) – Stay Invested
Market NewsUpcoming Stock Splits This Week (July 28 to August 1) – Stay Invested
4h ago
AGRI
AIHS
Biodexa Pharmaceuticals Announces ADR Ratio Change Effective July 31, 2025
PremiumCompany Announcements
Biodexa Pharmaceuticals Announces ADR Ratio Change Effective July 31, 2025
12d ago
6K
BDRX
Biodexa Pharmaceuticals files CTA in Europe for Phase 3 Serenta trial
PremiumThe Fly
Biodexa Pharmaceuticals files CTA in Europe for Phase 3 Serenta trial
13d ago
BDRX
Biodexa Pharmaceuticals Announces Successful AGM Resolutions
PremiumCompany Announcements
Biodexa Pharmaceuticals Announces Successful AGM Resolutions
30d ago
6K
BDRX
Biodexa announces activation of first clinical study site for Serenta trial
PremiumThe Fly
Biodexa announces activation of first clinical study site for Serenta trial
1M ago
BDRX
Biodexa Pharmaceuticals unveils ‘Serenta’ as name for upcoming Phase 3 FAP study
PremiumThe FlyBiodexa Pharmaceuticals unveils ‘Serenta’ as name for upcoming Phase 3 FAP study
1M ago
BDRX
Biodexa Pharmaceuticals Announces Successful Passing of General Meeting Resolutions
Premium
Company Announcements
Biodexa Pharmaceuticals Announces Successful Passing of General Meeting Resolutions
2M ago
6K
BDRX
Biodexa Pharmaceuticals Initiates Phase 2 Study for Type 1 Diabetes Treatment
Premium
Company Announcements
Biodexa Pharmaceuticals Initiates Phase 2 Study for Type 1 Diabetes Treatment
2M ago
6K
BDRX
Biodexa announces recruitment of first patient in Phase 2 tolimidone study
PremiumThe Fly
Biodexa announces recruitment of first patient in Phase 2 tolimidone study
2M ago
BDRX
Biodexa Pharmaceuticals Provides Shareholder Update and Advances eRapa Phase 3 Program
PremiumCompany Announcements
Biodexa Pharmaceuticals Provides Shareholder Update and Advances eRapa Phase 3 Program
2M ago
6K
BDRX
Biodexa Pharmaceuticals sees cash runway into 1Q26
PremiumThe Fly
Biodexa Pharmaceuticals sees cash runway into 1Q26
2M ago
BDRX
Biodexa Pharmaceuticals Releases 2024 Annual Report and Announces AGM
PremiumCompany Announcements
Biodexa Pharmaceuticals Releases 2024 Annual Report and Announces AGM
2M ago
6K
BDRX
Biodexa Pharmaceuticals Plans Share Capital Reorganization and New Share Allotment
PremiumCompany AnnouncementsBiodexa Pharmaceuticals Plans Share Capital Reorganization and New Share Allotment
2M ago
6K
BDRX
Biodexa Pharmaceuticals Secures Additional $3M Grant for eRapa Phase 3 Program
Premium
Company Announcements
Biodexa Pharmaceuticals Secures Additional $3M Grant for eRapa Phase 3 Program
2M ago
6K
BDRX
Biodexa Pharmaceuticals announces award of additional $3M grant from CPRIT
Premium
The Fly
Biodexa Pharmaceuticals announces award of additional $3M grant from CPRIT
2M ago
BDRX
Biodexa Pharmaceuticals Lowers Warrant Exercise Price to Boost Capital
PremiumCompany Announcements
Biodexa Pharmaceuticals Lowers Warrant Exercise Price to Boost Capital
2M ago
6K
BDRX
Biodexa Pharmaceuticals Secures EU Orphan Drug Designation for eRapa in FAP
PremiumCompany Announcements
Biodexa Pharmaceuticals Secures EU Orphan Drug Designation for eRapa in FAP
3M ago
6K
BDRX
Biodexa Pharmaceuticals receives orphan drug designation in Europe for eRapa
PremiumThe Fly
Biodexa Pharmaceuticals receives orphan drug designation in Europe for eRapa
3M ago
BDRX
Biodexa Pharmaceuticals Faces Setback as Key Resolution Fails at General Meeting
PremiumCompany Announcements
Biodexa Pharmaceuticals Faces Setback as Key Resolution Fails at General Meeting
3M ago
6K
BDRX
Biodexa Pharmaceuticals Announces General Meeting for Strategic Share Resolutions
PremiumCompany AnnouncementsBiodexa Pharmaceuticals Announces General Meeting for Strategic Share Resolutions
3M ago
6K
BDRX
Biodexa Pharmaceuticals Reports 2024 Preliminary Results and 2025 Strategic Priorities
Premium
Company Announcements
Biodexa Pharmaceuticals Reports 2024 Preliminary Results and 2025 Strategic Priorities
4M ago
6K
BDRX
Biodexa reports preliminary FY24 EPS GBP (0.1)p vs GBP (2)p last year
Premium
The Fly
Biodexa reports preliminary FY24 EPS GBP (0.1)p vs GBP (2)p last year
4M ago
BDRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >